🕔5/9/2025 2:55:46 PM
Nanopharmaceutics, Inc., a clinical-stage pharmaceutical development company, announced NanoDOX® 1% Doxycycline Monohydrate hydrogel with oral doxycycline will be tested in male partners with Genital Mycoplasmas in The University of Western Australia Clinical Trial "Efficacy of treating asymptomatic infections to restore fertility: The RESETTER Study: A prospective, single-centre, multi-site clinical trial of the effect of a combined partner treatment program for clearance of asymptomatic genital Mycoplasmas on unexplained fertility and clinical pregnancy rates " (Registration number: ACTRN12624001180505).
Read Full Article▸